# IOBTQ (IO Biotech, Inc.) - SEC EDGAR Financial Statements

> IO Biotech, Inc. reported $39.96M in total assets and a net loss of $88.36M through December 31, 2024 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/IOBTQ
- Markdown: https://convexityos.com/fundamentals/IOBTQ.md
- SEC CIK: 0001865494
- Reporting currency: USD
- Latest filing period: September 30, 2025
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001865494&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2024 | -- | Dec 31, 2024 |
| Operating Income | FY 2024 | -$92.05M | Operating profit |
| Net Income | FY 2024 | -$88.36M | GAAP bottom line |
| Diluted EPS | FY 2024 | -$1.32 | Split-adjusted |
| Free Cash Flow | FY 2024 | -$81.06M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2025 | $30.66M | Total debt: $18.12M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Research & Development | $71.48M | $67.83M | $46.99M | $30.15M | $8.46M |
| Total Operating Expenses | $95.18M | $91.44M | $71.42M | $41.23M | $10.14M |
| **Operating Income** | -$95.18M | -$91.44M | -$71.42M | -$41.23M | -$10.14M |
| **EBITDA** | -$94.88M | -$91.24M | -$71.32M | -$41.23M | -- |
| Interest Expense | -- | -- | $302K | $361K | $26K |
| Income Before Tax | -$94.05M | -$85.23M | -$70.19M | -$67.81M | -$12.04M |
| Income Tax Expense | $1.44M | $852K | $1.27M | $68K | -- |
| **Net Income** | -$95.50M | -$86.08M | -$71.46M | -$67.88M | -$12.04M |
| Basic EPS | -$1.45 | -$1.98 | -$2.48 | -$17.30 | -$82.36 |
| **Diluted EPS** | -$1.45 | -$1.98 | -$2.48 | -$17.30 | -$82.36 |
| Basic Shares Outstanding | 65.9M | 43.5M | 28.8M | 4.3M | 177.2K |
| Diluted Shares Outstanding | 65.9M | 43.5M | 28.8M | 4.3M | 177.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $13.74M | $16.65M | $16.38M | $21.15M | $20.18M | $15.85M | $14.31M | $21.77M |
| Total Operating Expenses | $19.36M | $23.17M | $22.58M | $26.94M | $26.50M | $21.53M | $20.20M | $28.18M |
| **Operating Income** | -$19.36M | -$23.17M | -$22.58M | -$26.94M | -$26.50M | -$21.53M | -$20.20M | -$28.18M |
| **EBITDA** | -$19.25M | -$23.07M | -$22.48M | -$26.84M | -$26.40M | -$21.43M | -$20.10M | -$28.18M |
| Interest Income | $255K | $285K | -- | -- | $1.07M | $1.31M | -- | -- |
| Income Before Tax | -$10.04M | -$26.10M | -$22.27M | -$30.89M | -$23.81M | -$20.31M | -$19.04M | -$25.83M |
| Income Tax Expense | -$1.66M | $118K | $146K | $445K | $209K | $374K | $415K | $353K |
| **Net Income** | -$8.38M | -$26.22M | -$22.42M | -$31.34M | -$24.02M | -$20.69M | -$19.46M | -$26.18M |
| Basic EPS | -$0.13 | -$0.40 | -$0.34 | -- | -$0.36 | -$0.31 | -$0.30 | -- |
| **Diluted EPS** | -$0.13 | -$0.40 | -$0.34 | -- | -$0.36 | -$0.31 | -$0.30 | -- |
| Basic Shares Outstanding | 66.9M | 65.9M | 65.9M | -- | 65.9M | 65.9M | 65.9M | -- |
| Diluted Shares Outstanding | 66.9M | 65.9M | 65.9M | -- | 65.9M | 65.9M | 65.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $60.03M | $143.2M | $142.6M | $211.5M | $3.40M |
| **Cash & Short-Term Investments** | $60.03M | $143.2M | $142.6M | $211.5M | $3.40M |
| **Total Current Assets** | $64.95M | $147.3M | $148.2M | $221.7M | $5.63M |
| Property, Plant & Equipment, Net | $638K | $847K | $741K | $155K | -- |
| Other Non-Current Assets | $117K | $89K | $84K | $127K | $18K |
| **Total Non-Current Assets** | $2.75M | $3.46M | $3.59M | $550K | $18K |
| **Total Assets** | $67.70M | $150.7M | $151.8M | $222.3M | $5.65M |
| Accounts Payable | $4.66M | $3.88M | $4.00M | $3.93M | $522K |
| Short-Term Debt | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $19.49M | $15.72M | $10.68M | $10.30M | $3.05M |
| Long-Term Debt | $0 | -- | -- | -- | -- |
| Other Non-Current Liabilities | -- | -- | -- | $59K | -- |
| **Total Non-Current Liabilities** | $1.20M | $1.84M | $2.27M | $59K | $0 |
| **Total Liabilities** | $20.68M | $17.56M | $12.95M | $10.36M | $3.05M |
| **Total Debt (incl. Leases)** | $1.92M | $2.49M | $2.79M | -- | -- |
| Common Stock | $66K | $66K | $29K | $29K | -- |
| Retained Earnings | -$359.3M | -$263.8M | -$177.7M | -$106.3M | -$38.40M |
| Accumulated Other Comp. Income | -$6.85M | -$9.67M | -$10.14M | -$1.49M | $1.96M |
| **Total Stockholders' Equity** | $47.02M | $133.2M | $138.9M | $211.9M | -$35.30M |
| Total Equity | $47.02M | $133.2M | $138.9M | $211.9M | -$35.30M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $30.66M | $28.13M | $37.09M | $60.03M | $80.19M | $100.7M | $118.0M | $143.2M |
| **Cash & Short-Term Investments** | $30.66M | $28.13M | $37.09M | $60.03M | $80.19M | $100.7M | $118.0M | $143.2M |
| **Total Current Assets** | $36.83M | $38.98M | $42.34M | $64.95M | $86.24M | $107.7M | $124.1M | $147.3M |
| Property, Plant & Equipment, Net | $544K | $603K | $617K | $638K | $695K | $735K | $788K | $847K |
| Other Non-Current Assets | $1.01M | $1.00M | $924K | $117K | $924K | $876K | $883K | $89K |
| **Total Non-Current Assets** | $3.12M | $3.35M | $3.39M | $2.75M | $3.70M | $3.81M | $4.03M | $3.46M |
| **Total Assets** | $39.96M | $42.33M | $45.74M | $67.70M | $89.94M | $111.5M | $128.2M | $150.7M |
| Accounts Payable | $5.59M | $5.54M | $5.20M | $4.66M | $5.26M | $5.02M | $3.84M | $3.88M |
| Short-Term Debt | -- | -- | $0 | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $18.31M | $19.90M | $18.29M | $19.49M | $16.05M | $13.72M | $11.04M | $15.72M |
| Long-Term Debt | $16.66M | $6.72M | $0 | $0 | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $20.73M | $20.84M | $1.03M | $1.20M | $1.32M | $1.47M | $1.65M | $1.84M |
| **Total Liabilities** | $39.05M | $40.73M | $19.31M | $20.68M | $17.38M | $15.20M | $12.69M | $17.56M |
| **Total Debt (incl. Leases)** | $18.12M | $8.36M | $1.76M | $1.92M | $2.02M | $2.15M | $2.32M | $2.49M |
| Common Stock | $70K | $66K | $66K | $66K | $66K | $66K | $66K | $66K |
| Retained Earnings | -$416.3M | -$408.0M | -$381.7M | -$359.3M | -$328.0M | -$304.0M | -$283.3M | -$263.8M |
| Accumulated Other Comp. Income | -$7.17M | -$6.81M | -$6.59M | -$6.85M | -$11.00M | -$9.63M | -$9.47M | -$9.67M |
| **Total Stockholders' Equity** | $911K | $1.59M | $26.42M | $47.02M | $72.56M | $96.27M | $115.5M | $133.2M |
| Total Equity | $911K | $1.59M | $26.42M | $47.02M | $72.56M | $96.27M | $115.5M | $133.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$95.49M | -$86.08M | -$71.46M | -$67.88M | -$12.04M |
| Depreciation & Amortization | $300K | $200K | $100K | $0 | -- |
| Stock-Based Compensation | $6.53M | $8.06M | $7.04M | $1.79M | $64K |
| Change in Payables | $782K | -$126K | $77K | $3.41M | -$475K |
| **Operating Cash Flow** | -$82.35M | -$71.74M | -$59.73M | -$40.65M | -$9.96M |
| Capital Expenditure | -$44K | -$323K | -$690K | -$153K | -- |
| **Free Cash Flow** | -$82.39M | -$72.06M | -$60.42M | -$40.80M | -- |
| **Investing Cash Flow** | -$44K | -$323K | -$690K | -$153K | -- |
| Common Stock Issued | -- | -- | -- | $115.1M | -- |
| **Financing Cash Flow** | -- | $71.86M | -- | $253.0M | $5.10M |
| **Net Change in Cash** | -$82.39M | -$200K | -$60.42M | $212.2M | -$4.85M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.38M | -$26.22M | -$22.42M | -$31.33M | -$24.02M | -$20.69M | -$19.46M | -$26.18M |
| Depreciation & Amortization | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $0 |
| Stock-Based Compensation | $1.48M | $1.61M | $1.57M | $1.63M | $1.68M | $1.64M | $1.57M | $1.56M |
| Change in Payables | $50K | $339K | $538K | -$596K | $239K | $1.18M | -$38K | -$2.77M |
| **Operating Cash Flow** | -$18.48M | -$19.82M | -$23.07M | -$19.62M | -$20.81M | -$16.98M | -$24.93M | -$22.80M |
| Capital Expenditure | -$4.0K | -$26K | -$28K | -$11K | -$10K | -$12K | -$11K | -$112K |
| **Free Cash Flow** | -$18.48M | -$19.85M | -$23.10M | -$19.64M | -$20.82M | -$16.99M | -$24.94M | -$22.91M |
| **Investing Cash Flow** | -$4.0K | -$26K | -$28K | -$11K | -$10K | -$12K | -$11K | -$112K |
| **Financing Cash Flow** | $21.27M | $11.49M | $0 | -- | $0 | $0 | $0 | -- |
| **Net Change in Cash** | $2.79M | -$8.36M | -$23.10M | -$19.64M | -$20.82M | -$16.99M | -$24.94M | -$22.92M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -203.1% | -64.6% | -51.5% | -32.0% | -- |
| Return on Assets (ROA) | -141.1% | -57.1% | -47.1% | -30.5% | -213.0% |
| Current Ratio | 3.33x | 9.37x | 13.88x | 21.52x | 1.85x |
| Quick Ratio | 3.08x | 9.11x | 13.36x | 20.53x | 1.12x |
| Debt to Equity | 0.04x | 0.02x | 0.02x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -9699.0% | -6532.3% | -372.7% | -203.1% | -124.5% | -91.4% | -76.6% | -64.6% |
| Return on Assets (ROA) | -221.1% | -245.7% | -215.3% | -141.1% | -100.4% | -79.0% | -69.1% | -57.1% |
| Current Ratio | 2.01x | 1.96x | 2.32x | 3.33x | 5.37x | 7.84x | 11.24x | 9.37x |
| Quick Ratio | 1.67x | 1.41x | 2.03x | 3.08x | 4.99x | 7.34x | 10.68x | 9.11x |
| Debt to Equity | 19.89x | 5.25x | 0.07x | 0.04x | 0.03x | 0.02x | 0.02x | 0.02x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
